Pfizer said a mid-stage study of its investigational CDK4 inhibitor atirmociclib met its key goal in certain patients with breast cancer. Pfizer on Tuesday said the randomized Phase 2 study met its ...

Placebo-adjusted mean weight loss of 16.3% (39 lbs) at 180 mg and 16.0% (37 lbs) at 240 mg at 44 weeks with no evidence of weight loss plateau in ACCESS II, demonstrating highest efficacy among oral ...

WHAT THEY ARE DOING TO COMBAT THE CONSTRUCTION. WITH THE PENN AVENUE PHASE TWO STREETSCAPE PROJECT IS COMPLETE. THIS AREA HERE WILL HAVE NEW SIDEWALKS, TRAFFIC LIGHTS AND A LOT MORE. HOWEVER, BUSINESS ...

Pfizer (PFE) said its Phase 2 study of tilrekimig (PF-07275315), a trispecific antibody for atopic dermatitis, showed positive results. The study met its primary endpoint, with tilrekimig showing a ...

Gibson Oncology, a clinical-stage private pharmaceutical company headquartered in Miami, announced it has entered Phase 2 clinical trials with LMP744 for the treatment of first-time recurrent ...

Global, randomized Phase 2 study to evaluate the addition of givastomig, a CLDN18.2 x 4-1BB bispecific antibody (8 mg/kg and 12 mg/kg) to standard of care immunochemotherapy in patients with first ...

A Metropolitan Transportation Authority rendering shows a conceptual interior of a future Second Avenue Subway station in Harlem, illustrating platform circulation, train clearances and passenger flow ...

Bright Minds (DRUG) Biosciences announced positive and significant topline results from its Phase 2 BREAKTHROUGH clinical trial evaluating BMB-101, a selective 5-HT2C biased agonist, in adult patients ...

Michael Block is a 14 time GLAM Award nominated writer, producer, and host of the podcast Block Talk. Throughout his time in the entertainment industry, he has worked on and off Broadway as a stage ...

LAWRENCE, Kan. (KCTV) - The next phase of the University of Kansas’ renovation of David Booth Kansas Memorial Stadium and the accompanying Gateway District project is underway. Construction crews ...

Kelluu produces hydrogen-powered airships, providing aerial sensing capability as a service. Above, testing during NATO ‘REPMUS 2025'. (NATO DIANA) NATO's Defence Innovation Accelerator for the North ...